Researchers at Weill Cornell Medicine, the College of Veterinary Medicine at Cornell University and the National Institutes of Allergy and Infectious Diseases (NIAID) have found that immunocompromised patients fighting persistent COVID-19 infections can harbor drug-resistant variants of SARS-CoV-2, which have the potential to spread to the general population.
News Release • September 19, 2024